You have reached the HIVandHepatitis.com legacy site. Please visit our new site at hivandhepatitis.com

 HIV and AIDS
 Hepatitis C
 Hepatitis B
HIV and Hepatitis.com
 Google Custom Search

HCV - Drug Abuse / Injection Drug Use

Little Change in Hepatitis C Risk among Injection Drug Users
2-11-2011

Hepatitis C Virus Can Survive in Syringes Up to 2 Months under Favorable Conditions

2-23-2010

Advocates Urge Consideration of Hepatitis C Treatment for Active Injection Drug Users
8-14-2009

HCV Reinfection and Superinfection Are Common among Injection Drug Users

3/24/09

Further Evidence Shows that Hepatitis C Virus (HCV) Can Be Transmitted through Snorting Drugs
9/19/08

Active Injection Drug Use Does Not Impair Sustained Response to Hepatitis C Treatment in Adherent Patients
7/22/08

Prevalence of Hepatitis C Virus Infection among Injection Drug Users in the U.S.
7/11/08

FDA Revises Process for Responding to Drug Approval Applications from Pharmaceutical Companies
7/11/08

Active and Recovering Injection Drug Users Can Benefit from Hepatitis C Treatment if They Maintain Good Adherence
6/10/08

Marijuana Use Sparks Liver Transplant Controversy
6/06/08

Alcohol, Tobacco, and Cannabis All May Promote Liver Disease Progression in People with Chronic Hepatitis C
3/28/08

Methamphetamine Promotes Hepatitis C Virus Replication in Human Liver Cells
3/07/08

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hepatits C Articles by Topic
HCV FDA-approved Treatments
HCV Experimental Treatments
Cirrhosis
Fibrosis
Hepatocellular Carcinoma
Liver Transplantation
Liver Biopsy

Steatosis
Anemia
Chilren / Infants / Women
Drug Abuse
Experimental Treatments
FAQs About Hepatitis C
Genotypes
Insulin Resistance / Diabetes
Sustained Viral Response (SVR)
Tests for HCV
Vaccines for HCV